{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:18:09Z","timestamp":1758874689899,"version":"3.40.5"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.yebeh.2019.01.018","type":"journal-article","created":{"date-parts":[[2019,3,2]],"date-time":"2019-03-02T05:09:28Z","timestamp":1551503368000},"page":"73-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Developmental outcomes at age four following maternal antiepileptic drug use"],"prefix":"10.1016","volume":"93","author":[{"given":"Noni","family":"Richards","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Reith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6498-9725","authenticated-orcid":false,"given":"Michael","family":"Stitely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1056-9527","authenticated-orcid":false,"given":"Alesha","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2019.01.018_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131130","article-title":"Congenital anomalies in children of mothers taking antiepileptic drugs with and without Periconceptional high dose folic acid use: a population-based cohort study","volume":"10","author":"Ban","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0010","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1017\/S1092852900008464","article-title":"The consequences of uncontrolled epilepsy","volume":"9","author":"Sperling","year":"2004","journal-title":"CNS Spectr"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0015","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ajmg.c.30306","article-title":"Influencing clinical practice regarding the use of antiepileptic medications during pregnancy: modeling the potential impact on the prevalences of spina bifida and cleft palate in the United States","volume":"157C","author":"Gilboa","year":"2011","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0020","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1176\/appi.ajp.2007.06101639","article-title":"Risk of recurrence in women with bipolar disorder during pregnancy: Prospective study of mood stabilizer discontinuation","volume":"164","author":"Viguera","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0025","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1474-4422(12)70323-X","article-title":"Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study","volume":"12","author":"Meador","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0030","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/jnnp-2012-304270","article-title":"The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs","volume":"84","author":"Bromley","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0035","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/jamaneurol.2017.5035","article-title":"Association between prenatal valproate exposure and performance on standardized language and mathematics tests in school-aged children","volume":"75","author":"Elkjaer","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0040","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1111\/epi.12226","article-title":"Exposure to antiepileptic drugs in utero and child development: a prospective population-based study","volume":"54","author":"Veiby","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0045","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.yebeh.2011.06.014","article-title":"Fetal antiepileptic drug exposure: motor, adaptive, and emotional\/behavioral functioning at age 3\u202fyears","volume":"22","author":"Cohen","year":"2011","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0050","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.yebeh.2013.08.001","article-title":"Fetal antiepileptic drug exposure: adaptive and emotional\/behavioral functioning at age 6\u202fyears","volume":"29","author":"Cohen","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0055","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ntt.2016.01.001","article-title":"Behavioral outcomes in children exposed prenatally to lamotrigine, valproate, or carbamazepine","volume":"54","author":"Deshmukh","year":"2016","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0060","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.yebeh.2013.08.033","article-title":"Preschool behavioral problems in children prenatally exposed to antiepileptic drugs \u2014 a follow-up study","volume":"29","author":"Kjaer","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0065","unstructured":"Ministry of Health. B4 School Check \u2014 performance against targets and eligible population In: 2015\/2016."},{"year":"2008","series-title":"The B4 school check: A handbook for practitioners","author":"Ministry of Health","key":"10.1016\/j.yebeh.2019.01.018_bb0070"},{"year":"2013","series-title":"PEDS Standardization","author":"PEDStest","key":"10.1016\/j.yebeh.2019.01.018_bb0075"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0080","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1365-2214.2000.00173.x","article-title":"Evidence-based approach to developmental and behavioural surveillance using parents' concerns","volume":"26","author":"Glascoe","year":"2000","journal-title":"Child Care Health Dev"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0085","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1469-7610.1997.tb01545.x","article-title":"The strengths and difficulties questionnaire: a research note","volume":"38","author":"Goodman","year":"1997","journal-title":"J Child Psychol Psychiatry"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0090","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1192\/bjp.177.6.534","article-title":"Using the strengths and difficulties questionnaire (SDQ) to screen for child psychiatric disorders in a community sample","volume":"177","author":"Goodman","year":"2000","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0095","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.comppsych.2012.07.009","article-title":"Psychometric properties of the strengths and difficulties questionnaire(3-4) in 3-year-old preschoolers","volume":"54","author":"Ezpeleta","year":"2013","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0100","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1212\/WNL.0b013e31820d62c7","article-title":"Language skills of school-aged children prenatally exposed to antiepileptic drugs","volume":"76","author":"Nadebaum","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0105","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1111\/j.1528-1167.2007.01376.x","article-title":"Intellectual and language functions in children of mothers with epilepsy","volume":"48","author":"Thomas","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0110","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1212\/WNL.0b013e318250d824","article-title":"Effects of fetal antiepileptic drug exposure: outcomes at age 4.5 years","volume":"78","author":"Meador","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/jnnp.70.1.15","article-title":"Additional educational needs in children born to mothers with epilepsy","volume":"70","author":"Adab","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.yebeh.2008.01.010","article-title":"Motor and mental development of infants exposed to antiepileptic drugs in utero","volume":"13","author":"Thomas","year":"2008","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0125","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1212\/01.WNL.0000154514.82948.69","article-title":"Neuropsychological effects of exposure to anticonvulsant medication in utero","volume":"64","author":"Vinten","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0130","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/adc.2009.176990","article-title":"Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine","volume":"96","author":"Cummings","year":"2011","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0135","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa0803531","article-title":"Cognitive function at 3\u202fyears of age after fetal exposure to antiepileptic drugs","volume":"360","author":"Meador","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0140","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1192\/bjp.bp.111.093070","article-title":"Intellectual disability and other neuropsychiatric outcomes in high-risk children of mothers with schizophrenia, bipolar disorder and unipolar major depression","volume":"200","author":"Morgan","year":"2012","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0145","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1001\/archpsyc.1990.01810240032006","article-title":"Longitudinal study of diagnoses in children of women with unipolar and bipolar affective disorder","volume":"47","author":"Hammen","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0150","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0155","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/acps.12032","article-title":"Prenatal antidepressant exposure and behavioral problems in early childhood\u2014a cohort study","volume":"127","author":"Pedersen","year":"2013","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0160","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.eplepsyres.2015.09.003","article-title":"Children (10\u201312\u202fyears age) of women with epilepsy have lower intelligence, attention and memory: observations from a prospective cohort case control study","volume":"117","author":"Gopinath","year":"2015","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0165","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006323","article-title":"Prevalence and predictors of alcohol use during pregnancy: findings from international multicentre cohort studies","volume":"5","author":"O'Keeffe","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0170","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(11)70107-7","article-title":"Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry","volume":"10","author":"Tomson","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0175","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1212\/01.wnl.0000289511.20864.2a","article-title":"Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency","volume":"70","author":"Pennell","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0180","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1528-1167.2007.01471.x","article-title":"Plasma concentrations of lamotrigine and its 2-N-glucuronide metabolite during pregnancy in women with epilepsy","volume":"49","author":"Ohman","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0185","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/epi4.12086","article-title":"Are doses of lamotrigine or levetiracetam adjusted during pregnancy?","volume":"3","author":"Richards","year":"2018","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta22230","article-title":"AntiEpileptic drug Monitoring in PREgnancy (EMPiRE): a double-blind randomised trial on effectiveness and acceptability of monitoring strategies","volume":"22","author":"Thangaratinam","year":"2018","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0195","doi-asserted-by":"crossref","first-page":"e811","DOI":"10.1212\/WNL.0000000000006073","article-title":"Verbal abilities in children of mothers with epilepsy: association to maternal folate status","volume":"91","author":"Husebye","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0200","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/jamaneurol.2017.3897","article-title":"Association of folic acid supplementation during pregnancy with the risk of autistic traits in children exposed to antiepileptic drugs in utero","volume":"75","author":"Bjork","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0205","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/jpc.13169","article-title":"Pre-school screening for developmental and emotional health: comparison with neurodevelopmental assessment","volume":"52","author":"Burakevych","year":"2016","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0210","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s12884-015-0745-3","article-title":"Medication use during pregnancy, gestational age and date of delivery: agreement between maternal self-reports and health database information in a cohort","volume":"15","author":"Pisa","year":"2015","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.yebeh.2019.01.018_bb0215","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00001648-200109000-00006","article-title":"Do pregnant women report use of dispensed medications?","volume":"12","author":"Olesen","year":"2001","journal-title":"Epidemiology"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505018307819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505018307819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T09:16:57Z","timestamp":1721035017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505018307819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":43,"alternative-id":["S1525505018307819"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.01.018","relation":{},"ISSN":["1525-5050"],"issn-type":[{"type":"print","value":"1525-5050"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developmental outcomes at age four following maternal antiepileptic drug use","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}